Working towards an accommodating intraocular lens

In the Netherlands, about 500,000 people suffer from a severe eye-related disease – such as corneal infection, cataract, glaucoma, macular degeneration or diabetic retinopathy – and the total costs of visual impairment to Dutch society exceed M€ 1,800 bn each year. Glasses and lenses restore vision; eye drops and injections treat disease and prevent associated complications, e.g. from surgeries. But lenses are expensive and uncomfortable, and eye drops are often ineffective because they are not in the eye long enough to deliver the drug and patient compliance is low. Worse, serious side effects can occur and even lead to blindness.

Chemelot InSciTe